Citation 143664

SHIMIZU,K: KONDO,R: SAKAI,K:. (2000). INHIBITION OF TYROSINASE BY FLAVONOIDS, STILBENES AND RELATED 4-SUBSTITUTED RESORCINOLS: STRUCTURE-ACTIVITY INVESTIGATIONS.. 66(1)

Citation Details

Title	INHIBITION OF TYROSINASE BY FLAVONOIDS, STILBENES AND RELATED 4-SUBSTITUTED RESORCINOLS: STRUCTURE-ACTIVITY INVESTIGATIONS.
Authors	SHIMIZU,K: KONDO,R: SAKAI,K:
Year	2000
Volume	66
Issue	1

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,(DL):	INACTIVE
2	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOCEMBRIN,(-):	INACTIVE
3	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,(DL):	INACTIVE
4	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AROMADENDRIN,(+):	INACTIVE
5	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUSTIN,(DL):	INACTIVE
6	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN,(DL):	INACTIVE
7	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN,DIHYDRO: (+):	INACTIVE
8	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN,DIHYDRO: (+):	ACTIVE
9	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTOCARPANONE,NOR: (+):	ACTIVE
10	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	INACTIVE
11	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	INACTIVE
12	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
13	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	WEAK ACTIVITY
14	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
15	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	INACTIVE
16	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTOCARPIN	INACTIVE
17	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	INACTIVE
18	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTOCARPESIN	ACTIVE
19	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTOCARPESIN,ISO:	ACTIVE
20	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANGOLENSIN,(-):	INACTIVE
21	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOSYLVIN	INACTIVE
22	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,OXY:	ACTIVE
23	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,4-PRENYL-OXY:	ACTIVE
24	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROPHORIN	ACTIVE
25	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTOCARBENE	ACTIVE
26	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZALDEHYDE,2-4-DIHYDROXY:	INACTIVE
27	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETOPHENONE,2-4-DIHYDROXY:	INACTIVE
28	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOIC ACID,2-4-DIHYDROXY:	INACTIVE
29	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZAMIDE,2-4-DIHYDROXY-N-(2-HYDROXY-ETHYL):	INACTIVE
30	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPHENONE,2-4-DIHYDROXY:	INACTIVE
31	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESORCINOL	ACTIVE
32	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESORCINOL,4-METHYL:	ACTIVE
33	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESORCINOL,4-HEXYL:	ACTIVE
34	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESCORINOL,4-DODECYL	ACTIVE
35	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESORCINOL,4-ETHYL:	ACTIVE
36	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESORCINOL,4-PROPYL:	ACTIVE

Citation 143664

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1